As Good as Chocolate

See allHide authors and affiliations

Science  03 May 2013:
Vol. 340, Issue 6132, pp. 562-563
DOI: 10.1126/science.1238521

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


No one could have imagined how important the 1948 discovery of the vasoconstrictor serotonin (5-hydroxytryptamine or 5-HT) would be to the field of human physiology (1). Elucidation of the 5-HT structure (2) and synthesis of the molecule with the expected biological activity (3) soon followed. This monoamine is a ligand for 15 receptors, and drugs that target 5-HT receptors are widely used to treat conditions including migraine headache, depression, anxiety, nausea, vomiting, and irritable bowel syndrome, reflecting the wide diversity of physiological and pathophysiological processes in which 5-HT is involved (4). On page 615 and 610 in this issue, Wacker et al. (5) and Wang et al. (6), respectively, report the crystal structure of human 5-HT2B bound to the antimigraine agent ergotamine and compare it with the 5-HT1B-ergotamine structure. Together with biochemical and computational data, these structures reveal molecular mechanisms responsible for divergent signaling patterns of ergotamine, serotonin, and the psychedelic drug lysergic acid diethylamide (LSD).